Billiontoone (NASDAQ:BLLN) Trading Down 6.8% – Here’s Why

Billiontoone, Inc. (NASDAQ:BLLN)’s share price traded down 6.8% during trading on Tuesday . The company traded as low as $74.55 and last traded at $74.2080. 49,464 shares were traded during trading, a decline of 82% from the average session volume of 267,659 shares. The stock had previously closed at $79.59.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on BLLN shares. Guggenheim reiterated a “buy” rating and issued a $120.00 price target on shares of Billiontoone in a report on Thursday, March 5th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Stifel Nicolaus began coverage on shares of Billiontoone in a research note on Monday, December 1st. They issued a “buy” rating and a $145.00 price objective on the stock. Weiss Ratings started coverage on shares of Billiontoone in a report on Tuesday, February 3rd. They set a “sell (d)” rating for the company. Finally, Wells Fargo & Company lowered their price target on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $129.57.

Billiontoone Price Performance

The business’s fifty day simple moving average is $80.95. The stock has a market capitalization of $3.54 billion and a P/E ratio of 366.67. The company has a current ratio of 11.69, a quick ratio of 11.32 and a debt-to-equity ratio of 0.12.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.07. The firm had revenue of $96.05 million for the quarter, compared to analysts’ expectations of $85.85 million. Billiontoone’s quarterly revenue was up 113.0% on a year-over-year basis.

Institutional Trading of Billiontoone

Institutional investors and hedge funds have recently made changes to their positions in the business. Rossby Financial LCC purchased a new position in shares of Billiontoone during the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN purchased a new position in Billiontoone during the fourth quarter valued at $76,000. Smartleaf Asset Management LLC purchased a new stake in shares of Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone during the 4th quarter worth about $82,000. Finally, Renaissance Capital LLC purchased a new position in Billiontoone in the 4th quarter valued at about $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.